BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 51 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $646,862 | -14.5% | 653,000 | -13.3% | 0.00% | 0.0% |
| Q2 2023 | $756,995 | +3.2% | 753,000 | +7.1% | 0.00% | 0.0% |
| Q1 2023 | $733,233 | +4.5% | 703,000 | +7.7% | 0.00% | -50.0% |
| Q4 2022 | $701,688 | +8.3% | 653,000 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $648,000 | -0.2% | 653,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $649,000 | -0.8% | 653,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $654,000 | +13.9% | 653,000 | +18.7% | 0.00% | 0.0% |
| Q4 2021 | $574,000 | +70.3% | 550,000 | +63.2% | 0.00% | 0.0% |
| Q3 2021 | $337,000 | +50.4% | 337,000 | +50.4% | 0.00% | – |
| Q2 2021 | $224,000 | – | 224,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 52,002 | $52,121,000 | 3.69% |
| MACKAY SHIELDS LLC | 77,043,000 | $76,896,000 | 1.94% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,534,000 | $33,470,000 | 0.61% |
| LOOMIS SAYLES & CO L P | 2,190,467 | $185,686,000 | 0.38% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,143,000 | $3,139,000 | 0.09% |
| Jefferies Group LLC | 8,306,000 | $8,275,194 | 0.07% |
| THRIVENT FINANCIAL FOR LUTHERANS | 15,950,000 | $15,840,000 | 0.04% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 13,700,000 | $13,605,000 | 0.03% |
| FORESIGHT CAPITAL MANAGEMENT ADVISORS, INC. | 14,000 | $14,000 | 0.02% |
| AVIVA PLC | 3,000,000 | $3,005,000 | 0.02% |